Complement-Based Drug Development Summit leaderboard
  • Sunday, August 23, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

17th World ADC San Diego Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 194

Author

Pharma Journalist 9017 posts 0 comments

Avadel Pharmaceuticals Enters into Royalty Agreement with RTW Investments for up to $75 Million

Mar 29, 2023
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced its entry into a royalty agreement with RTW Investments, LP and…
Read More...

Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize…

Mar 29, 2023
Théa Open Innovation (“TOI”), a sister company of ophthalmic specialty pharmaceutical company Laboratoires Théa, and Galimedix Therapeutics, Inc. (“Galimedix”), a clinical-stage…
Read More...

Libtayo (cemiplimab) in Combination with Chemotherapy Approved by European Commission for the…

Mar 29, 2023
Regeneron Pharmaceuticals, Inc. announced that the European Commission (EC) approved Libtayo (cemiplimab) in combination with platinum-based chemotherapy for the first-line treatment of…
Read More...

Aquestive Therapeutics Expands License and Supply Agreement with Pharmanovia for Libervant…

Mar 29, 2023
Aquestive Therapeutics, Inc. announced it has expanded its exclusive license and supply agreement with Atnahs Pharma UK Limited (“Pharmanovia”), a global pharmaceutical company that…
Read More...

Regeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize…

Mar 29, 2023
Regeneron Pharmaceuticals, Inc. and Sonoma Biotherapeutics, Inc. announced a collaboration to apply their scientific and clinical expertise and respective technology platforms to the…
Read More...

OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient…

Mar 28, 2023
OncoVent Co., Ltd., a majority-controlled subsidiary of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (the "Company"), yesterday entered into a license agreement with Orient…
Read More...

Covant and Boehringer Ingelheim Collaborate to Develop a Novel ADAR1 Inhibitor for Use in Cancer…

Mar 28, 2023
Covant Therapeutics, an innovative covalent drug discovery company, has entered into an exclusive research collaboration and worldwide licensing agreement with Boehringer Ingelheim…
Read More...

Takeda Receives Approval to Manufacture and Market Entyvio Subcutaneous Injection in Japan for the…

Mar 27, 2023
Takeda Pharmaceutical Company Limited announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of Entyvio Pens for subcutaneous (SC) injection 108 mg /…
Read More...

Teva’s Digital Health Collaboration with Rimidi Expands to Include Respiratory Monitoring Program…

Mar 27, 2023
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced that a respiratory patient monitoring program using data from Teva’s Digihaler System has been…
Read More...

Thermo Fisher Scientific Opens Cell Therapy Facility at University of California, San Francisco, to…

Mar 27, 2023
Thermo Fisher Scientific Inc., the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to…
Read More...
Prev Next
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Biomarker Operations & Biospecimen Management
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
10th IPF Summit
Model-Informed Drug Development Summit 2026
IMPACCT Real-World Evidence Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Piramal Pharma Takes Majority Stake in Yapan Bio
  • Charles River and Medigen Partner on Next-Generation Enterovirus Vaccine
  • WellSpan and Johns Hopkins Expand Cancer Care Collaboration
  • SandboxAQ Launches AI Model to Speed Drug Discovery
  • FDA Approves Ultragenyx Gene Therapy for Rare GSDIa Disorder

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver…

2nd T-Cell Engager for Autoimmune Disease Summit Returns in…

New Era for Autoimmune T-Cell Engagers Takes Centre Stage…

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.